Autism In Women May Be As Common As In Men, Study Finds
A large Swedish cohort study of 2.7 million children tracked over 35 years shows that while boys are diagnosed more often in childhood, the male‑to‑female autism ratio narrows to about 1.2 by age 20 and may reach parity in adulthood. The findings suggest the historic 4:1 gender gap reflects diagnostic bias rather than true prevalence differences. Girls often camouflage symptoms, leading to later diagnoses and higher rates of co‑occurring mental‑health issues. The study calls for gender‑sensitive screening tools and earlier interventions.
Half of Americans Believe only the Rich Can Afford GLP-1s without Insurance
A ValuePenguin study finds that a median‑income American household would need to allocate about 7.3% of earnings to afford a two‑milligram monthly supply of Ozempic, the flagship GLP‑1 weight‑loss drug. In the poorest states, the cost can approach one‑tenth of...
Dual Wielding in I&I: A Pivotal Year Ahead
The article argues that the next breakthrough in immunology and inflammation (I&I) therapeutics will come from multi‑drug and multi‑target strategies rather than single‑target antibodies, which have hit an efficacy ceiling. It traces the evolution from early blockbuster biologics like Humira...
IT Execs Seek to Tame Application Sprawl Without Stifling Innovation Through Shared Governance
In a healthsystemCIO webinar, senior IT leaders from RWJBarnabas Health, Ardent Health Services, and the University of Maryland Medical System discussed how to manage the flood of application requests while fostering innovation. They emphasized establishing a single, standardized intake point,...
STAT+: Ocular’s Experimental Eye Drug Beats Low Dose of Regeneron’s Eylea in Late-Stage Trial
Ocular Therapeutix announced that its experimental drug Axpaxli met the primary endpoint in a Phase 3 trial for wet age‑related macular degeneration, maintaining vision in 74% of patients at nine months and 66% at one year after a single injection....
Size‐Transformable Supramolecular Nanoprodrugs Enable Redox Imbalance Amplification and Cholesterol Modulation to Boost Multidimensional Tumor Immunotherapy
Researchers have engineered a tumor‑targeting, tumor‑microenvironment‑responsive supramolecular nanoprodrug that switches size to enhance deep tumor penetration. The nanoprodrug simultaneously induces redox imbalance—accumulating reactive nitrogen species and depleting glutathione—to amplify ferroptosis, while depleting cholesterol to rejuvenate exhausted T cells. This multidimensional...
PH‐Responsive Nanoparticle‐Coated Calcium Phosphate Granules for Bone Cancer Therapy
Researchers have engineered β‑tricalcium phosphate (β‑TCP) granules coated with selenium‑doped mesoporous silica nanoparticles (SeMIA) linked via pH‑responsive imine–alendronate bonds. The imine linkers remain stable at physiological pH but cleave in the mildly acidic osteosarcoma microenvironment, releasing nanoparticles that selectively kill...
Suspendable and Scalable Ultrasound‐Actuated ZnO‐Nanosheet‐Based Piezoelectric Microdevices for Wireless Electrical Stimulation of Cells
Researchers have created subcellular-sized, silicon‑based microdevices that incorporate ZnO nanosheets to act as piezoelectric generators. When deformed by cellular forces or external ultrasound within the biomedical range, these nanostructures produce localized electrical potentials that depolarize cell membranes and trigger calcium...
STAT+: Compass Says Its Psilocybin Drug Helped Patients with Severe Depression in Two Trials
Compass Pathways announced that its synthetic psilocybin therapy, COMP360, achieved statistically significant improvements in two identical Phase 3 trials for severe major depressive disorder. Both studies met primary endpoints, showing greater reduction in depression scores than placebo‑controlled psychotherapy. The data suggest...
Welltower / Multiple Care Homes Merger Inquiries
The UK Competition and Markets Authority (CMA) has opened a phase‑1 merger inquiry into Welltower Inc.’s recent acquisition of more than 600 care homes from Barchester, HC‑One, Aria Care and Danforth Care. The regulator has already served initial enforcement orders...
The German Digital Healthcare Act (DVG) at Seven Years: Review of the DiGA Ecosystem and Its Impact on European Health...
Seven years after Germany’s Digital Healthcare Act (DVG) introduced the world’s first reimbursement pathway for digital health apps, the DiGA ecosystem has matured from speculative beginnings to a €234 million market serving nearly one million prescriptions. The fast‑track approval process accelerated...
Strategic Commissioning Plan for Leicestershire and Northamptonshire ICBs Notes Digital to Transform Population Health, Neighbourhood Health, and Prevention
The Leicester, Leicestershire and Rutland ICB and Northamptonshire ICB have released a five‑year strategic commissioning plan to 2031 that places digital and data at the core of population health, neighbourhood health and prevention initiatives. A new digital and data strategy...
Revolutionizing Healthcare: The Transformative Impact of Artificial Intelligence
Artificial intelligence is moving from hype to concrete healthcare applications, as highlighted in a new AIAInow session featuring Stanford Medicine and Starkey Hearing. The event showcases AI’s role in diagnostics, where neural networks now exceed human specialists, and the transformation...
Selecting the Optimal Cell Therapy Manufacturing Platform
Developers of cell and gene therapies must choose between fully integrated turnkey platforms and modular, multi‑device systems. Integrated solutions deliver rapid time‑to‑value and simplified workflows, ideal for low‑volume autologous products, but they restrict reagent flexibility and scale. Modular platforms provide...
How to Evaluate Prospective Diagnostic Laboratory Partners for Your Patient Support Program
The pharmaceutical industry now invests over $5 billion annually in patient support programs (PSPs), which boost adherence by roughly 30 % and lower overall healthcare costs. Diagnostic laboratory testing is a cornerstone of these programs, delivering timely data that guides dosing, monitors...
Listen: Why Do I Need Prior Authorization?
Prior authorization is a pre‑approval step insurers require before covering a prescription or treatment. The criteria triggering a request remain opaque, turning even routine care into a paperwork marathon for physicians. Patients often endure delays, risking condition worsening while providers...
Case Study: University Hospitals of Northamptonshire Optimising Clinical Pathways Through Digital
University Hospitals of Northamptonshire partnered with Isla Health to digitise and re‑engineer clinical pathways across 15 specialties, eliminating manual bottlenecks. The overhaul slashed paediatric epilepsy processing from three days to ten minutes and cut pain‑management referral times from eight days...
CStone Secures FDA Clearance to Begin CS2009 Phase II Trial
CStone Pharmaceuticals has secured FDA clearance for its investigational new drug application, allowing the launch of a Phase II trial of CS2009, a trispecific antibody that simultaneously targets PD‑1, VEGFA and CTLA‑4. The global study uses a parallel, multi‑cohort expansion design...
ExCellThera Secures German NUB Status 1 Listing for Zemcelpro
ExCellThera and its subsidiary Cordex Biologics have secured a Status 1 listing under Germany’s NUB programme for their cell therapy Zemcelpro (dorocubicel). The therapy, which received conditional marketing authorisation from the European Commission, targets adults with haematological malignancies lacking suitable donor...
STAT+: As China’s Drug Industry Races Ahead, Its GLP-1 Race Is Accelerating Too
China’s pharmaceutical sector is rapidly expanding, now generating its own GLP‑1 drugs alongside imported treatments. Novo Nordisk reported a 5% decline in Ozempic sales in China last year, the first dip since its 2021 launch, while sales grew elsewhere. The...
Sources: US Healthcare Manufacturer Danaher Is Nearing a Deal to Buy Medtech Company Masimo for ~$10B; Masimo Is in an...
Danaher, a US healthcare conglomerate, is close to finalizing a roughly $10 billion acquisition of Masimo, the maker of pulse‑oximetry and other medical monitoring devices. The deal, still subject to antitrust clearance, would add Masimo’s sensor technology to Danaher’s Life Sciences...
Biopharma Must Cope With The Fetal Bovine Serum Squeeze
Biopharma faces a tightening fetal bovine serum (FBS) market as U.S. cattle inventories hit record lows and European disease outbreaks curb supply. Prices have surged more than 300% over five years and release timelines have lengthened from weeks to months...
Red Light Therapy Shows Promise for Treating Brain Injuries
A University of Utah Health study examined red‑light photobiomodulation (PBM) as a preventive therapy for repetitive head acceleration events in collegiate football. Twenty‑six Division I athletes were randomized to active or sham transcranial and intranasal PBM over 16 weeks, receiving three...
Paras Health Appoints Balkishan Sharma as CHRO
Paras Health has appointed Balkishan Sharma as chief human resources and business transformation officer, a move that underscores the network’s drive toward operational excellence and growth. Sharma returns after a six‑year stint with the group and brings more than 18...
Radiologists Urge Cigna to Rescind Coverage Restriction for Key Imaging Procedure
Radiology societies, led by the Society of Interventional Radiology, have asked Cigna to reverse policy 0539, which labels implantable peripheral nerve stimulation (PNS) for chronic pain as medically unnecessary. The groups cite robust randomized trials, FDA clearance, and a favorable...
Montana Hospital Restores Phones as Cyber-Related Network Disruptions Persist
Livingston HealthCare in Montana announced that its phone system has been fully restored after a recent cybersecurity incident forced the hospital to shut down communications and other network services. The disruption, first reported on Feb. 13, stemmed from a potential...
Brain Differences Between Sexes Get More Pronounced From Puberty
A new preprint analyzing fMRI data from 1,286 participants aged 8‑100 finds that sex differences in brain connectivity are minimal in childhood but expand sharply at puberty and continue diverging into adulthood. Using an AI model called Krakencoder, researchers identified...
FastFinance: Cost Implications of New HOPD Reporting Rules; Election Year Opportunity on Affordability
HFMA’s FastFinance podcast highlights new off‑campus HOPD reporting requirements that could impose significant cost burdens on health systems. The episode also cites a "Weird Number"—a 3‑5% annual net revenue loss attributed to inefficient electronic health records and billing platforms. Additionally,...
How Smart Hospitals Push Forward From Pilot to Practice
Smart hospital rooms equipped with interactive displays, sensors, and AI are moving from pilot projects to core infrastructure in new builds and retrofits. The global market, valued at $67 billion in 2024, is expected to nearly triple by 2030 as health...
Big Financial Impacts From Off-Campus HOPD Rule Change
Effective Jan. 1 2028, the Consolidated Appropriations Act of 2026 requires hospitals to assign separate NPIs and submit two provider‑based attestations for each off‑campus hospital outpatient department (HOPD) or lose Medicare OPPS reimbursement. Compliance documentation can be extensive—up to 200 pages per...
Leveraging AI to Predict Patient Deterioration
Dr. Michael Spaeder will present at HIMSS26 on using AI‑enabled analysis of continuous bedside cardiorespiratory monitoring to detect patient deterioration earlier than traditional electronic health record methods. He will contrast predictive insights from live physiologic data with retrospective EHR analytics,...
FDA Approval of Sibeprenlimab Signals New Era in IgA Nephropathy: Jackson Peter Kim, MD
The FDA granted accelerated approval to sibeprenlimab‑szsi (Voyxact) for primary IgA nephropathy, marking the first APRIL‑inhibiting monoclonal antibody for this condition. Interim results from the phase 3 VISIONARY trial showed a 50 % reduction in proteinuria at nine months versus 2 % with...
HIMSS26: AdventHealth CEO to Give Keynote Address at the Executive Summit
AdventHealth President and CEO David Banks will deliver the opening keynote at HIMSS26’s Executive Summit in Las Vegas, titled “Leading Through Healthcare’s Perfect Storm.” He will frame the current systemic headwinds as an opportunity to shift from episodic, diagnosis‑centric care to...
Have Money, Will Travel: A16z’s Hunt for the Next European Unicorn
Andreessen Horowitz (a16z) led a $2.3 million pre‑seed round in Swedish AI dental startup Dentio, marking the firm’s first bite into Sweden’s health‑tech ecosystem. The investment follows a16z’s broader strategy of deploying scouts and partners across Europe to capture early‑stage AI...
Reclaiming Nursing Time for Patient Care Through Better Automation
Healthcare faces a looming shortage of over 63,000 full‑time registered nurses by 2030, intensifying pressure on existing staff. Manual tasks such as charting and medication administration divert nurses from bedside care, prompting a push for smarter automation. Omnicell’s new Titan...
Compassionate Leadership in Times of Disruption
Healthcare leaders traditionally separate emotion from decision‑making, but a recent hospital closure in New York demonstrates that compassionate leadership can coexist with operational rigor. The tertiary medical center reduced from 700 to 200 beds, faced financial loss, and ultimately closed...
Vaccine Makers Curtail Research and Cut Jobs
Federal policies driven by Health Secretary Robert F. Kennedy Jr. are creating a hostile environment for vaccine developers, prompting companies like Moderna to scale back late‑stage studies. A Texas startup canceled a new manufacturing plant, and a San Diego firm...
HIMSSCast: 2026 Could Be the Most Challenging Year yet for Medicare Advantage Payers
Medicare Advantage insurers are confronting a perfect storm of rising medical costs and a flat payment increase of less than 1% announced by CMS for 2026. The new risk‑adjustment formula and stagnant reimbursement fall below the medical‑cost trend, compressing margins...
Dr. Oz Endorses AI Avatars for Rural Mental Health Access
Dr. Mehmet Oz, CMS administrator, advocated AI avatars as the most effective solution to bridge mental‑health gaps in rural America. He highlighted the chronic shortage of clinicians and argued that agentic AI can conduct early intakes, detect subtle speech cues,...
Md. FD Whole Blood Program Saves 14 Lives Since Inception
Carroll County, Maryland launched a Whole Blood Program in May, enabling paramedics to carry and transfuse 500‑ml Type O‑positive units on scene. The initiative has saved 14 lives and been used 17 times, with 100% survival for internal hemorrhage cases...
Prime Healthcare Pits Two Virtual Sitter Vendors Against One Another – Who Won?
Prime Healthcare conducted a nine‑month, 13‑hospital trial of two virtual sitter models—an integrated turnkey vendor and a split‑component approach—to enhance patient safety in Phase 2 of its virtual care strategy. The integrated model, which supplies hardware, software, and remote observers, outperformed...
2025 Q4 Job Market Report: Positive Signs Emerge for Job Seekers
The fourth quarter of 2025 marked the first quarter‑over‑quarter rise in biopharma job postings, with a 10% increase and a 4% uptick in average listings, despite a 14% year‑over‑year decline. Science/research and development roles grew 14% while clinical positions surged...
Curbside Consult with Dr. Jayne 2/16/26
The article traces the shifting terminology of digital health records, noting that the "electronic health record" (EHR) label gained popularity during the Bush 43 era while earlier versions were called CPR and later EMR. It argues the rebranding served vendor pricing...
Should Drug Companies Be Advertising to Consumers?
Direct‑to‑consumer advertising for prescription drugs is resurging, highlighted by Novo Nordisk’s $180 million spend on Ozempic TV spots in 2022 and $189 million in 2023. The ads use upbeat jingles and lifestyle imagery to present the GLP‑1 medication as a gateway to...
Produce Prescription Program Shows Limited Impact on Cardiometabolic Health in Diabetes
A pragmatic randomized trial in the southeastern US tested a 12‑month produce‑prescription program that gave diabetes patients at risk of food insecurity an $80 monthly debit card for fruits and vegetables. After enrolling 2,155 participants, the intervention showed no significant...
Readers Write: Medicare Goes All In on Value-Based Care
Medicare announced a sweeping transition to value‑based care, extending bundled‑payment and quality‑adjusted reimbursement models to virtually all Medicare‑eligible services. The initiative introduces new performance metrics that link payments directly to patient outcomes, with quarterly reporting requirements for participating providers. Early...
HIMSS26 Session Offers a Prescription to End Confusion
At HIMSS26, Greg O'Neill, director of Patient & Family Health Education at ChristianaCare, presented a session titled “A Prescription to End Confusion.” The talk highlighted a new organizational goal to boost health literacy across clinical workflows. O'Neill explained how clearer...
Implications of FDA Digital Health Deregulation for Clinicians
On Jan 2026 the FDA issued updated guidance that relaxes oversight for low‑risk digital health products, including many AI‑enabled clinical decision support tools and consumer wellness wearables. The guidance clarifies which software falls outside the medical device definition, allowing these tools...
From Pilots to Protocols: Why VR Therapy Needs Dosage Standards to Become Real Clinical Care
Virtual reality (VR) therapy shows rapid clinical effects but remains confined to pilot studies due to a lack of standardized dosage protocols. Researchers highlight wide variation in session length, frequency, and content across studies, preventing reliable comparison and scaling. The...
When Health Dollars Move to Individuals, Infrastructure Will Decide Who Wins
The article examines a proposed federal framework that would shift health‑affordability dollars into individual‑controlled accounts, highlighting that ownership of the payment infrastructure will decide market winners. It points to the rapid growth of high‑deductible plans, Health Savings Accounts exceeding $100 billion,...